NZ Rare 9 Graff.png (43.8 kB)

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

Download (43.8 kB)
figure
posted on 28.02.2018, 08:46 by Gavin R. Graff, John McNamara, James Royall, Steven Caras, Kristin Forssmann

The full text of this article can be found here:

https://link.springer.com/article/10.2165/11533390-000000000-00000


Funding

Solvay Pharmaceuticals, Inc.

History

Licence

Exports

Logo branding

Licence

Exports